| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
AZD-7687 manufacturers
- AZD7687
-
- $1120.00
-
2026-04-21
- CAS:1166827-44-6
- Purity:
- Supply Ability: 10g
- AZD7687
-
- $1120.00
-
2025-10-28
- CAS:1166827-44-6
- Purity:
- Supply Ability: 10g
|
| | AZD-7687 Basic information |
| Product Name: | AZD-7687 | | Synonyms: | AZD 7687;AZD7687;AZD-7687;[trans-4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl]acetic acid;Cyclohexaneacetic acid, 4-[4-[6-(aminocarbonyl)-3,5-dimethyl-2-pyrazinyl]phenyl]-, trans-;AZD7687,AZD-7687 | | CAS: | 1166827-44-6 | | MF: | C21H25N3O3 | | MW: | 367.44 | | EINECS: | | | Product Categories: | | | Mol File: | 1166827-44-6.mol |  |
| | AZD-7687 Chemical Properties |
| Boiling point | 527.5±50.0 °C(Predicted) | | density | 1.201±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Powder | | pka | 4.72±0.10(Predicted) | | color | Off-white to pink |
| | AZD-7687 Usage And Synthesis |
| Uses | AZD7687 is a novel, potent, selective and reversible inhibitor of diglyceride acyltransferase-1 (DGAT-1). | | in vivo | Prolonged pharmacological inhibition of DGAT1 with AZD7687 in mice results in the same skin phenotype, including sebaceous gland atrophy and alopecia, as seen in the skin of DGAT1-/- mice. AZD7687-mediated effects on the skin were dose- and time-dependent and reversible[3]. |
| | AZD-7687 Preparation Products And Raw materials |
|